Potent induction of chondrocytic differentiation of human adipose‐derived adult stem cells by bone morphogenetic protein 6

Bradley T. Estes, Arthur W. Wu, Farshid Guilak

Arthritis & Rheumatism · 2006 · 296 citations · 47 references

Concepts

TL;DR

Human adipose‑derived adult stem cells (ADAS) are a plentiful, multipotent cell source that can differentiate into chondrocyte‑like cells with TGFβ1, but the role of other growth factors in this process remains unclear. The study aimed to evaluate how combinations of TGFβ1, TGFβ3, IGF‑1, BMP‑6, and dexamethasone affect the chondrogenic potential of ADAS cells encapsulated in alginate beads. Chondrogenic responses were quantified by qPCR, ³H‑proline and ³⁵S‑sulfate incorporation, and immunolabeling of extracellular matrix proteins. BMP‑6 strongly promoted chondrogenesis, elevating AGC1 and COL2A1 expression 205‑ and 38‑fold while suppressing COL10A1, indicating that BMP‑6–containing regimens could steer ADAS cells toward cartilage repair applications.

Abstract

Abstract Objective Recent studies have identified an abundant source of multipotent progenitor cells in subcutaneous human adipose tissue, termed human adipose‐derived adult stem cells (ADAS cells). In response to specific media formulations, including transforming growth factor β1 (TGFβ1), these cells exhibit significant ability to differentiate into a chondrocyte‐like phenotype, expressing cartilage‐specific genes and proteins such as aggrecan and type II collagen. However, the influence of other growth factors on the chondrogenic differentiation of ADAS cells is not fully understood. This study was undertaken to investigate the effects of TGFβ1, TGFβ3, insulin‐like growth factor 1, bone morphogenetic protein 6 (BMP‐6), and dexamethasone, in various combinations, on the chondrogenic potential of ADAS cells in alginate beads. Methods The chondrogenic response of alginate‐encapsulated ADAS cells was measured by quantitative polymerase chain reaction, 3 H‐proline and 35 S‐sulfate incorporation, and immunolabeling for specific extracellular matrix components. Results Significant differences in chondrogenesis were observed under the different culture conditions for all outcomes measured. Most notably, BMP‐6 up‐regulated AGC1 and COL2A1 expression by an average of 205‐fold and 38‐fold, respectively, over day‐0 controls, while down‐regulating COL10A1 expression by ∼2‐fold. Conclusion These findings suggest that BMP‐6 is a potent inducer of chondrogenesis in ADAS cells, in contrast to mesenchymal stem cells, which exhibit increased expression of type X collagen and a hypertrophic phenotype in response to BMP‐6. Combinations of growth factors containing BMP‐6 may provide a novel means of regulating the differentiation of ADAS cells for applications in the tissue‐engineered repair or regeneration of articular cartilage.

References

47